Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinoma

BACKGROUND: In clinical practice, the detection of biomarkers is mostly based on primary tumors for its convenience in acquisition. However, immune checkpoints may express differently between primary and metastatic tumor. Therefore, we aimed to compare the differential expressions of PD-1, PD-L1 and...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xingming, Yin, Xiaoxue, Zhang, Haoran, Sun, Guangxi, Yang, Yaojing, Chen, Junru, Zhu, Xudong, Zhao, Peng, Zhao, Jinge, Liu, Jiandong, Chen, Ni, Wang, Jia, Shen, Pengfei, Zeng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469103/
https://www.ncbi.nlm.nih.gov/pubmed/30992011
http://dx.doi.org/10.1186/s12885-019-5578-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469103/
https://www.ncbi.nlm.nih.gov/pubmed/30992011
http://dx.doi.org/10.1186/s12885-019-5578-4

Ejemplares similares